Purpose:
The aim of this study is to compare the generic and ostomy-specific quality of life (QoL) between cancer and non-cancer ostomy patients using a mixed-method design.
Methods:
All patients with an ostomy participating in the Stomapanel of the Dutch Ostomy Association were asked to complete a generic (RAND-36) and ostomy-specific (Stoma-QoL) QoL questionnaire. In addition, open-ended questions on symptoms, restrictions or adaptations influencing daily life were included. The generic and ostomy-specific QoL between cancer and non-cancer ostomy patients were compared using linear regression analyses. Qualitative responses were analysed using content analysis.
Results:
In total, 668 patients were included: 379 cancer patients (80 % colorectal, 17 % bladder and 3 % other) and 289 non-cancer patients (38 % colitis ulcerosa, 22 % Crohn's disease and 40 % other) with a colostomy (55 %), ileostomy (31 %) and/or urostomy (16 %). Adjusted for gender, age, type of ostomy and time elapsed since ostomy surgery, cancer ostomy patients scored higher (better) on Stoma-QoL (β = 2.1) and all RAND-36 domains (9.1 < β ≤ 19.5) except on mental health compared to non-cancer ostomy patients. Of the 33 themes coded for in the content analysis, fatigue or sleeplessness, leakages, pain, bladder or bowel complaints, physical functioning or activity, travelling or being away from home, other daily activities (including work), clothing and diet were among the 10 most frequently reported themes, although ranking differed between both patient groups. Besides, cancer ostomy patients frequently reported on the impact on (engaging in a) relationship or sexual intimacy and non-cancer ostomy patients frequently reported to be relieved of symptoms and restrictions in daily life.
Conclusions:
Cancer patients reported better generic and ostomy-specific QoL than non-cancer ostomy patients. In both cancer and non-cancer ostomy patients, fatigue or sleeplessness, leakages, pain, bladder or bowel complaints, physical functioning or activity, travelling or being away from home, other daily activities (including work), clothing and diet were among the 10 most common reported themes influencing daily life. However, the ranking of these 10 most common themes was different in both patient groups.
Citing Articles
Self-Care and Quality of Life of Ostomy Patients: A Structural Equation Modeling Analysis.
Marcomini I, Iovino P, Rasero L, Manara D, Vellone E, Villa G
Nurs Rep. 2024; 14(4):3417-3426.
PMID: 39585138
PMC: 11587398.
DOI: 10.3390/nursrep14040247.
Prospective nutrition-inflammation markers for predicting early stoma-related complications in patients with colorectal cancer undergoing enterostomy.
Yuan J, Jiang F, Fu X, Hou Y, Hu Y, Yang Q
Front Oncol. 2024; 14:1409503.
PMID: 39246321
PMC: 11377279.
DOI: 10.3389/fonc.2024.1409503.
A Continuous Registry of Medical Record, Patient Input, and Epidemiological Data of Patients With Ulcerative Colitis: a Multicentre, Prospective, Observational Clinical Registry Study in Japan.
Matsuoka K, Hibiya S, Ando K, Tani Y, Torisu T, Ogino H
Ann Clin Epidemiol. 2024; 6(3):65-72.
PMID: 39034943
PMC: 11254582.
DOI: 10.37737/ace.24010.
Systematic Literature Review: Ability of the IBDQ-32 to Detect Meaningful Change in Ulcerative Colitis Health Indicators.
Dubinsky M, Rice A, Yarlas A, Hur P, Cappelleri J, Kulisek N
Inflamm Bowel Dis. 2023; 30(11):2115-2126.
PMID: 38150386
PMC: 11532591.
DOI: 10.1093/ibd/izad282.
Experience of providing care to a family member with Crohn's disease and a temporary stoma: A qualitative study.
Liu S, Sun B, Tian W, Zhang L, Kong F, Wang M
Heliyon. 2023; 9(10):e21013.
PMID: 37886749
PMC: 10597855.
DOI: 10.1016/j.heliyon.2023.e21013.
Nursing Intervention for Quality of Life in Patients with Ostomy: A Systematic Review.
Heydari A, Manzari Z, Pouresmail Z
Iran J Nurs Midwifery Res. 2023; 28(4):371-383.
PMID: 37694203
PMC: 10484385.
DOI: 10.4103/ijnmr.ijnmr_266_22.
Persisting Deficits in Health-Related Quality of Life of Colorectal Cancer Survivors 14-24 Years Post-Diagnosis: A Population-Based Study.
Thong M, Doege D, Weisser L, Koch-Gallenkamp L, Jansen L, Bertram H
Curr Oncol. 2023; 30(3):3373-3390.
PMID: 36975470
PMC: 10047200.
DOI: 10.3390/curroncol30030257.
A cancer survivorship model for holistic cancer care and research.
Sheikh-Wu S, Anglade D, Downs C
Can Oncol Nurs J. 2023; 33(1):4-16.
PMID: 36789222
PMC: 9894370.
DOI: 10.5737/236880763314.
.
Sheikh-Wu S, Anglade D, Downs C
Can Oncol Nurs J. 2023; 33(1):17-30.
PMID: 36789217
PMC: 9894373.
DOI: 10.5737/2368807633117.
Quality of Life in Inflammatory Bowel Diseases (IBDs) Patients after Surgery.
Di Candido F
Rev Recent Clin Trials. 2022; 17(4):227-239.
PMID: 35959618
DOI: 10.2174/1574887117666220811143426.
Patient reported outcome measures assessing quality of life in patients with an intestinal stoma: A systematic review.
Skibsted C, Jensen B, Juul T, Kristensen H
Colorectal Dis. 2022; 24(10):1128-1139.
PMID: 35639396
PMC: 9796962.
DOI: 10.1111/codi.16202.
The Inflammatory Bowel Disease Questionnaire in Randomized Controlled Trials of Treatment for Ulcerative Colitis: Systematic Review and Meta-Analysis.
Yarlas A, Maher S, Bayliss M, Lovley A, Cappelleri J, Bushmakin A
J Patient Cent Res Rev. 2020; 7(2):189-205.
PMID: 32377552
PMC: 7197888.
DOI: 10.17294/2330-0698.1722.
Psychometric validation of the work productivity and activity impairment questionnaire in ulcerative colitis: results from a systematic literature review.
Yarlas A, Maher S, Bayliss M, Lovley A, Cappelleri J, DiBonaventura M
J Patient Rep Outcomes. 2018; 2(1):62.
PMID: 30547275
PMC: 6292832.
DOI: 10.1186/s41687-018-0088-8.
Changes in health-related quality of life and work-related outcomes for patients with mild-to-moderate ulcerative colitis receiving short-term and long-term treatment with multimatrix mesalamine: a prospective, open-label study.
Willian M, DHaens G, Yarlas A, Joshi A
J Patient Rep Outcomes. 2018; 2:22.
PMID: 30294708
PMC: 6092727.
DOI: 10.1186/s41687-018-0046-5.
Improving Health-Related Quality of Life of Patients With an Ostomy Using a Novel Digital Wearable Device: Protocol for a Pilot Study.
Rouholiman D, Gamble J, Dobrota S, Encisco E, Shah A, Grajales Iii F
JMIR Res Protoc. 2018; 7(3):e82.
PMID: 29581087
PMC: 5891667.
DOI: 10.2196/resprot.7470.
Tofacitinib in Patients with Ulcerative Colitis: Health-Related Quality of Life in Phase 3 Randomised Controlled Induction and Maintenance Studies.
Panes J, Vermeire S, Lindsay J, Sands B, Su C, Friedman G
J Crohns Colitis. 2017; 12(2):145-156.
PMID: 29028981
PMC: 5881763.
DOI: 10.1093/ecco-jcc/jjx133.